ACAD
30.3
-1.13
-3.60%
AEMD
5.88
-0.13
-2.16%
APRI
0.367
-0.033
-8.250%
ARNA
1.65
-0.16
-8.84%
ATEC
0.301
+0.021
+7.500%
CNAT
2
-0.04
-1.96%
CRXM
0.16
-0.015
-8.6015%
CYTX
2
-0.02
-0.99%
DXCM
75.91
-1.55
-2.00%
GNMK
8.14
-0.21
-2.51%
HALO
7.78
-0.66
-7.82%
ILMN
135.48
-3.43
-2.47%
INNV
0.215
-0.015
-6.522%
INO
8.29
-0.88
-9.60%
ISCO
1.91
-0.14
-6.83%
ISIS
57.56
0.00
0.00%
LGND
113.12
+1.33
+1.19%
LPTN
2.05
-0.13
-5.96%
MBVX
0.55
0.00
-0.45%
MEIP
1.27
-0.09
-6.62%
MNOV
6.96
-0.04
-0.57%
MRTX
5.55
-0.43
-7.19%
MSTX
0.464
+0.014
+3.203%
NBIX
41.79
-1.49
-3.44%
NUVA
57.79
-0.14
-0.24%
ONCS
1.59
-0.04
-2.45%
ONVO
3.1
-0.25
-7.46%
OREX
0.41
-0.039
-8.5784%
OTIC
14.93
-0.65
-4.17%
QDEL
16.67
-0.42
-2.46%
RCPT
231.96
0.00
0.00%
RGLS
5.01
-0.28
-5.29%
RMD
59.22
-1.3
-2.15%
SCIE
0.004
-0.001
-13.7255%
SPHS
1.72
-0.14
-7.53%
SRNE
5.49
-0.13
-2.31%
TROV
4.36
-0.19
-4.18%
VICL
4.22
-0.25
-5.59%
VOLC
18
0.00
0.00%
ZGNX
7.35
-0.74
-9.15%
ACAD
30.3
-1.13
-3.60%
AEMD
5.88
-0.13
-2.16%
APRI
0.367
-0.033
-8.250%
ARNA
1.65
-0.16
-8.84%
ATEC
0.301
+0.021
+7.500%
CNAT
2
-0.04
-1.96%
CRXM
0.16
-0.015
-8.6015%
CYTX
2
-0.02
-0.99%
DXCM
75.91
-1.55
-2.00%
GNMK
8.14
-0.21
-2.51%
HALO
7.78
-0.66
-7.82%
ILMN
135.48
-3.43
-2.47%
INNV
0.215
-0.015
-6.522%
INO
8.29
-0.88
-9.60%
ISCO
1.91
-0.14
-6.83%
ISIS
57.56
0.00
0.00%
LGND
113.12
+1.33
+1.19%
LPTN
2.05
-0.13
-5.96%
MBVX
0.55
0.00
-0.45%
MEIP
1.27
-0.09
-6.62%
MNOV
6.96
-0.04
-0.57%
MRTX
5.55
-0.43
-7.19%
MSTX
0.464
+0.014
+3.203%
NBIX
41.79
-1.49
-3.44%
NUVA
57.79
-0.14
-0.24%
ONCS
1.59
-0.04
-2.45%
ONVO
3.1
-0.25
-7.46%
OREX
0.41
-0.039
-8.5784%
OTIC
14.93
-0.65
-4.17%
QDEL
16.67
-0.42
-2.46%
RCPT
231.96
0.00
0.00%
RGLS
5.01
-0.28
-5.29%
RMD
59.22
-1.3
-2.15%
SCIE
0.004
-0.001
-13.7255%
SPHS
1.72
-0.14
-7.53%
SRNE
5.49
-0.13
-2.31%
TROV
4.36
-0.19
-4.18%
VICL
4.22
-0.25
-5.59%
VOLC
18
0.00
0.00%
ZGNX
7.35
-0.74
-9.15%
Home » Archive by Category

Xconomy

Regulus Shares Crumble As FDA Halts Testing of Hepatitis C Drug

June 27, 2016 – 2:45 pm

A new wave of drugs has changed the way hepatitis C is treated. Regulus Therapeutics has not been part of that wave, but the company’s plans to join it took a big hit this afternoon. La Jolla,…

[[Click headline to continue reading.]]

Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More

June 24, 2016 – 3:55 am

It’s a week for the history books. The United Kingdom voted to leave the European Union last night, triggering worldwide financial fears and, perhaps, a breakup of the U.K. itself. Closer to…

[[Click headline to continue reading.]]

IBM Watson Health Launches Imaging Effort for Cancer, Other Diseases

June 22, 2016 – 10:00 am

So far, the story of IBM Watson Health has been mostly about growth and potential. Today, it’s more about action. The healthcare computing giant, now headquartered in Cambridge, MA, is unveiling a…

[[Click headline to continue reading.]]

Radicle Accelerator Fund Launches to Nurture AgTech Innovation

June 22, 2016 – 4:30 am

Radicle, a new accelerator fund focused on agricultural ventures, is launching today with plans to seed and nurture the next generation of agtech companies addressing global farming problems. The new…

[[Click headline to continue reading.]]

Biotech Roundup: Kadmon Debt, Hemo Data, Loose Lips & More

June 17, 2016 – 3:30 am

Familiar biotech names—not necessarily familiar for the right reasons—made news this week in biotech. Data from a hematology conference stoked dreams of approval, though still on a far…

[[Click headline to continue reading.]]

Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More

June 10, 2016 – 3:30 am

If you blinked, you probably missed something this week in biotech. The nation’s biggest annual cancer meeting took place in Chicago, while biotech’s trade group held its annual confab in San…

[[Click headline to continue reading.]]

How to Make Healthcare Better? Make It Easy

June 8, 2016 – 5:59 am

There’s an “easy button” in the hospital that I press a hundred times every day. With each press, I make myself a better doctor. It’s not a button on a computer. It’s not electronic at all. It’s a…

[[Click headline to continue reading.]]

Biotech Roundup: Deals Gone Wrong, Ethical Red Flags & Bay Goodbyes

June 3, 2016 – 3:30 am

It was fitting this week that, in the lead-up to two of biomedicine’s biggest self-celebrations, we were served ample reminder of the industry’s expensive decisions gone wrong. This…

[[Click headline to continue reading.]]

Two Years After Paying $680M, BioMarin Shelves Duchenne Drug

May 31, 2016 – 2:44 pm

BioMarin Pharmaceutical took a $680 million gamble when it bought Prosensa in 2014 for its experimental Duchenne muscular dystrophy treatment. Drisapersen (Kydrisa) had already failed a Phase 3…

[[Click headline to continue reading.]]

With Recruits Coming, Precision Med Effort Pledges $142M For Biobank

May 27, 2016 – 11:56 am

The Obama administration’s ambitious long-term health study, dubbed the Precision Medicine Initiative, has tapped the Mayo Clinic to build a repository for biological samples collected from the…

[[Click headline to continue reading.]]